Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.

Oncotarget - 26 Jul 2016

Cheng Feifei, Su Li, Qian Cheng

Abstract excerpt

Tissue biopsy is the standard diagnostic procedure for cancers and also provides a material for genotyping, which can assist in the targeted therapies of cancers. However, tissue biopsy-based cancer diagnostic procedures have limitations in their assessment of cancer development, prognosis and genotyping, due to tumor heterogeneity and evolution. Circulating tumor DNA (ctDNA) is single- or double-stranded DNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Early Detection of Cancer
Share to Circulating Tumor DNA
Share to Genotyping Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liquid Biopsy

Share to Molecular Targeted Therapy

Share to Neoplasm Staging

Share to Neoplastic Cells, Circulating

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 27223063
DOI: 10.18632/oncotarget.9453
PMCID: PMC5217053

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.PMID 27223063Read ↗

Liquid biopsy: Comprehensive overview of circulating tumor DNA (Review)Semantic proximity Read ↗

Toward liquid biopsies in cancer treatment: application of circulating tumor DNASemantic proximity Read ↗

Circulating Tumor DNA as a Liquid Biopsy for CancerSemantic proximity Read ↗

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.Semantic proximity Read ↗

Revolution of Circulating Tumor DNA: From Bench Innovations to Bedside ImplementationsSemantic proximity Read ↗

Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection TechniquesSemantic proximity Read ↗

The feasibility of using mutation detection in ctDNA to assess tumor dynamics.Semantic proximity Read ↗

"Liquid biopsy"-ctDNA detection with great potential and challenges.Semantic proximity Read ↗

Circulating Tumor DNA as Biomarkers for Cancer DetectionSemantic proximity Read ↗

Liquid Biopsy: Approaches to Dynamic Genotyping in CancerSemantic proximity Read ↗

ctDNA as a Cancer Biomarker: A Broad OverviewSemantic proximity Read ↗

ctDNA as a cancer biomarker: A broad overview.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.